Poststroke depression as a factor adversely affecting the level of oxidative damage to plasma proteins during a brain stroke

Oxidative Medicine and Cellular Longevity

Volumn 2015, Issue , 2015, Pages

  Cichoń, Natalia ^a   Bijak, Michał ^a   Miller, Elzbieta ^b,c   Niwald, Marta ^b,c   Saluk, Joanna ^a,d  

^a UNIVERSITY OF LODZ   (Poland)

^b MEDICAL UNIVERSITY OF LODZ   (Poland)

^c Neurorehabilitation Ward III General Hospital in Lodz   (Poland)

^d WROCLAW MEDICAL UNIVERSITY   (Poland)

Author keywords

[No Author keywords available]

Indexed keywords

PROTEINS;

BIOCHEMICAL CHANGES; COGNITIVE IMPAIRMENT; CORRELATION ANALYSIS; GERIATRIC DEPRESSION SCALE; NEGATIVE CORRELATION; POSITIVE CORRELATIONS; POSTSTROKE DEPRESSION; SPECTROPHOTOMETRIC ASSAYS;

PATIENT REHABILITATION;

3 NITROTYROSINE; 5,5' DITHIOBIS(2 NITROBENZOIC ACID); CARBONYL DERIVATIVE; CATALASE; HYDROGEN PEROXIDE; PLASMA PROTEIN; THIOL; THIOL GROUP; 3-NITROTYROSINE; THIOL DERIVATIVE; TYROSINE;

AGED; ARTICLE; BRAIN ISCHEMIA; CLINICAL ARTICLE; COMPARATIVE STUDY; CONTROLLED STUDY; CONVALESCENCE; CORRELATION ANALYSIS; DECOMPOSITION; DEPRESSION; DISEASE SEVERITY; ENZYME ACTIVITY; ERYTHROCYTE; FEMALE; GERIATRIC DEPRESSION SCALE; HUMAN; MALE; NITRATIVE STRESS; OXIDATIVE STRESS; SPECTROPHOTOMETRY; STROKE PATIENT; ANALOGS AND DERIVATIVES; BLOOD; CEREBROVASCULAR ACCIDENT; COMPLICATION; ENZYME LINKED IMMUNOSORBENT ASSAY; ENZYMOLOGY; METABOLISM; MIDDLE AGED; PATHOLOGY; VERY ELDERLY;

AGED; AGED, 80 AND OVER; BLOOD PROTEINS; CATALASE; DEPRESSION; ENZYME-LINKED IMMUNOSORBENT ASSAY; ERYTHROCYTES; FEMALE; HUMANS; MALE; MIDDLE AGED; OXIDATIVE STRESS; SPECTROPHOTOMETRY; STROKE; SULFHYDRYL COMPOUNDS; TYROSINE;

EID: 84925679704     PISSN: 19420900     EISSN: 19420994     Source Type: Journal    
DOI: 10.1155/2015/408745     Document Type: Article

References (78)

1. I.G. Li, H. Y. Han, and H. S. Lee, "Emotional disorder of stroke patients," Journal of Korean Academy of RehabilitationMedicine, vol. 12, pp. 33-38, 1995.
2. A. Pan, Q. Sun, O. I. Okereke, K. M. Rexrode, and F. B. Hu, "Depression and risk of stroke morbidity andmortality: a metaanalysis and systematic review," The Journal of the American Medical Association, vol. 306, no. 11, pp. 1241-1249, 2011.
3. C. Ellis, Y. Zhao, and L. E. Egede, "Depression and increased risk of death in adults with stroke," Journal of Psychosomatic Research, vol. 68, no. 6, pp. 545-551, 2010.
4. P. Masskulpan, K. Riewthong, P. Dajpratham, and V. Kuptniratsaikul, "Anxiety and depressive symptoms after stroke in 9 rehabilitation centers," Journal of the Medical Association of Thailand, vol. 91, no. 10, pp. 1595-1602, 2008.
5. S. Paolucci, "Epidemiology and treatment of post-stroke depression," Neuropsychiatric Disease and Treatment, vol. 4, no. 1, pp. 145-154, 2008.
6. N. Hadidi, D. J. Treat-Jacobson, and R. Lindquist, "Poststroke depression and functional outcome: a critical review of literature," Heart and Lung, vol. 38, no. 2, pp. 151-162, 2009.
7. F. Ng, M. Berk, O. Dean, and A. I. Bush, "Oxidative stress inpsychiatric disorders: evidence base and therapeutic implications," International Journal of Neuropsychopharmacology, vol. 11, no. 6, pp. 851-876, 2008.
8. D. Radak, I. Resanovic, and E. R. Isenovic, "Link between oxidative stress and acute brain ischemia," Angiology, vol. 65, no. 8, pp. 667-676, 2014.
9. E. Miller, A. Walczak, J. Saluk, M. B. Ponczek, and I. Majsterek, "Oxidative modification of patient's plasma proteins and its role in pathogenesis ofmultiple sclerosis," Clinical Biochemistry, vol. 45, no. 1-2, pp. 26-30, 2012.
10. M. Maes, P. Galecki, Y. S. Chang, and M. Berk, "A review on the oxidative and nitrosative stress (O&NS) pathways in major depression and their possible contribution to the (neuro)degenerative processes in that illness," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 3, pp. 676-692, 2011.
11. M. Maes, "An intriguing and hitherto unexplained co-occurrence: depression and chronic fatigue syndrome are manifestations of shared inflammatory, oxidative and nitrosative (IO&NS) pathways," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 35, no. 3, pp. 784-794, 2011.
12. H. Suzuki and M. Colasanti, "NO: a molecule with two masks of 'NO' theatre," BioFactors, vol. 15, no. 2-4, pp. 123-125, 2001.
13. A. Dhir and S. K. Kulkarni, "Nitric oxide andmajor depression," Nitric Oxide, vol. 24, no. 3, pp. 125-131, 2011.
14. J. W. Gawryluk, J. F. Wang, A. C. Andreazza, L. Shao, and L. T. Young, "Decreased levels of glutathione, the major brain antioxidant, in post-mortem prefrontal cortex from patients with psychiatric disorders," International Journal of Neuropsychopharmacology, vol. 14, no. 1, pp. 123-130, 2011.
15. S.-Y. Lee, S.-J. Lee, C. Han, A. A. Patkar, P. S. Masand, and C.- U. Pae, "Oxidative/nitrosative stress and antidepressants: targets for novel antidepressants," Progress in Neuro-Psychopharmacology and Biological Psychiatry, vol. 46, pp. 224-235, 2013.
16. W. Dröge, "Free radicals in the physiological control of cell function," Physiological Reviews, vol. 82, no. 1, pp. 47-95, 2002.
17. K. Uchida and E. R. Stadtman, "Covalent attachment of 4-hydroxynonenal to glyceraldehyde-3-phosphate dehydrogenase. Apossible involvement of intra- and intermolecular crosslinking reaction," The Journal of Biological Chemistry, vol. 268, no. 9, pp. 6388-6393, 1993.
18. W. Li, C. Busu, M. L. Circu, and T. Y. Aw, "Glutathione in cerebral microvascular endothelial biology and pathobiology: implications for brain homeostasis," International Journal ofCell Biology, vol. 2012, Article ID 434971, 14 pages, 2012.
19. Y. Wang, J. Yang, and J. Yi, "Redox sensing by proteins: oxidative modifications on cysteines and the consequent events," Antioxidants and Redox Signaling, vol. 16, no. 7, pp. 649-657, 2012.
20. J. Sun and E. Murphy, "Protein S-nitrosylation and cardioprotection," Circulation Research, vol. 106, no. 2, pp. 285-296, 2010.
21. B. N. Manolescu, M. Berteanu, E. Oprea et al., "Dynamic of oxidative andnitrosative stressmarkersduring the convalescent period of stroke patients undergoing rehabilitation," Annals of Clinical Biochemistry, vol. 48, no. 4, pp. 338-343, 2011.
22. C. D. Reiter, R.-J. Teng, and J. S. Beckman, "Superoxide reacts with nitric oxide to nitrate tyrosine at physiological pH via peroxynitrite,"The Journal of Biological Chemistry, vol. 275, no. 42, pp. 32460-32466, 2000.
23. I. M. Cojocaru, M. Cojocaru, V. Sapira, and A. Ionescu, "Evaluation of oxidative stress in patients with acute ischemic stroke," Romanian Journal of Internal Medicine, vol. 51, no. 2, pp. 97-106, 2013.
24. T. R. Golden and M. Patel, "Catalytic antioxidants and neurodegeneration," Antioxidants & Redox Signaling, vol. 11, no. 3, pp. 555-569, 2009.
25. H. Buss, T. P. Chan, K. B. Sluis, N. M. Domigan, and C. C. Winterbourn, "Protein carbonyl measurement by a sensitive ELISA method," Free Radical Biology and Medicine, vol. 23, no. 3, pp. 361-366, 1997.
26. D. H. Alamdari, E. Kostidou, K. Paletas et al., "High sensitivity enzyme-linked immunosorbent assay (ELISA) method for measuring protein carbonyl in samples with low amounts of protein," Free Radical Biology and Medicine, vol. 39, no. 10, pp. 1362-1367, 2005.
27. M. Bijak, J. Kolodziejczyk-Czepas, M. B. Ponczek, J. Saluk, and P. Nowak, "Protective effects of grape seed extract against oxidative and nitrative damage of plasma proteins," International Journal of Biological Macromolecules, vol. 51, no. 3, pp. 183-187, 2012.
28. J. F. Koster, P. Biemond, and A. J. G. Swaak, "Intracellular and extracellular sulphydryl levels in rheumatoid arthritis," Annals of the Rheumatic Diseases, vol. 45, no. 1, pp. 44-46, 1986.
29. J. Khan, D. M. Brennand, N. Bradley, B. Gao, R. Bruckdorfer, and M. Jacobs, "3-Nitrotyrosine in the proteins of human plasma determined by an ELISA method," Biochemical Journal, vol. 330, part 2, pp. 795-801, 1998.
30. H. Ischiropoulos and A. B. Al-Mehdi, "Peroxynitrite-mediated oxidative protein modifications," FEBS Letters, vol. 364, no. 3, pp. 279-282, 1995.
31. R. F. Beers Jr. and I. W. Sizer, "A spectrophotometric method formeasuring the breakdown of hydrogen peroxide by catalase," The Journal of Biological Chemistry, vol. 195, no. 1, pp. 133-140, 1952.
32. W. R. Wallace and G. T. Dimopoullos, "Catalase activity in anaplasma marginale," Journal of Bacteriology, vol. 90, pp. 309-311, 1965.
33. J. Hauke and T. Kossowski, "Comparison of values of pearson's and spearman's correlation coefficients on the same sets of data," Quaestiones Geographicae, vol. 30, no. 2, pp. 87-93, 2011.
34. E. M. Whyte and B. H. Mulsant, "Post stroke depression: epidemiology, pathophysiology, and biological treatment," Biological Psychiatry, vol. 52, no. 3, pp. 253-264, 2002.
35. M.-L. Kauhanen, J. T. Korpelainen, P. Hiltunen et al., "Poststroke depression correlates with cognitive impairment and neurological deficits," Stroke, vol. 30, no. 9, pp. 1875-1880, 1999.
36. K. Narushima, K.-L. Chan, J. T. Kosier, and R. G. Robinson, "Does cognitive recovery after treatment of poststroke depression last? A 2-year follow-up of cognitive function associated with poststroke depression,"TheAmerican Journal of Psychiatry, vol. 160, no. 6, pp. 1157-1162, 2003.
37. H. Tiemeier, "Biological risk factors for late life depression," European Journal of Epidemiology, vol. 18, no. 8, pp. 745-750, 2003.
38. W. K. Tang, H. Liang, W. C. W. Chu, V. Mok, G. S. Ungvari, and K. S. Wong, "Association between high serum total bilirubin and post-stroke depression," Psychiatry and Clinical Neurosciences, vol. 67, no. 4, pp. 259-264, 2013.
39. L. Yang, Z. Zhang, D. Sun, Z. Xu, X. Zhang, and L. Li, "The serum interleukin-18 is a potential marker for development of post-stroke depression," Neurological Research, vol. 32, no. 4, pp. 340-346, 2010.
40. L. S. Rothenburg, N. Herrmann, W. Swardfager et al., "The relationship between inflammatory markers and post stroke cognitive impairment," Journal of Geriatric Psychiatry and Neurology, vol. 23, no. 3, pp. 199-205, 2010.
41. A. B. Gold, N. Herrmann, W. Swardfager et al., "The relationship between indoleamine 2,3-dioxygenase activity and post-stroke cognitive impairment," Journal of Neuroinflammation, vol. 8, article 17, 2011.
42. J. Huppert, D. Closhen, A. Croxford et al., "Cellularmechanisms of IL-17-induced blood-brain barrier disruption," The FASEB Journal, vol. 24, no. 4, pp. 1023-1034, 2010.
43. W. Swardfager, N. Herrmann, A. C. Andreazza et al., "Poststroke neuropsychiatric symptoms: relationships with IL-17 and oxidative stress," BioMed Research International, vol. 2014, Article ID 245210, 6 pages, 2014.
44. B. Halliwell, "Reactive species and antioxidants. Redox biology is a fundamental theme of aerobic life," Plant Physiology, vol. 141, no. 2, pp. 312-322, 2006.
45. R. H. Belmaker and G. Agam, "Major depressive disorder," The NewEngland Journal ofMedicine, vol. 358, no. 1, pp. 55-68, 2008.
46. Y. Dowlati, N. Herrmann, W. Swardfager et al., "A meta-analysis of cytokines in major depression," Biological Psychiatry, vol. 67, no. 5, pp. 446-457, 2010.
47. C. P. Chung, D. Schmidt, C. M. Stein, J. D. Morrow, and R. M. Salomon, "Increased oxidative stress in patientswith depression and its relationship to treatment," Psychiatry Research, vol. 206, no. 2-3, pp. 213-216, 2013.
48. A. Vogelgesang and A. Dressel, "Immunological consequences of ischemic stroke: Immunosuppression and autoimmunity," Journal of Neuroimmunology, vol. 231, no. 1-2, pp. 105-110, 2011.
49. A. R. Pachner, "Neuroimmunology of degenerative diseases and stroke ," in A Primer of Neuroimmunological Disease, pp. 155-158, Springer, Boston, Mass, USA, 2012.
50. C.-U. Pae, H.-S. Yu, T.-S. Kimet al., "Monocyte chemoattractant protein-1 (MCP1) promoter-2518 polymorphism may confer a susceptibility to major depressive disorder in the Korean population," Psychiatry Research, vol. 127, no. 3, pp. 279-281, 2004.
51. C.-U. Pae, D. M. Marks, C. Han, A. A. Patkar, and D. Steffens, "Does neurotropin-3 have a therapeutic implication in major depression?" International Journal of Neuroscience, vol. 118, no. 11, pp. 1515-1522, 2008.
52. A. Berg, J. Lönnqvist, H. Palomäki, and M. Kaste, "Assessment of depression after stroke a comparison of different screening instruments," Stroke, vol. 40, no. 2, pp. 523-529, 2009.
53. E. R. Stadtman and R. L. Levine, "Free radical-mediated oxidation of free amino acids and amino acid residues in proteins," Amino Acids, vol. 25, no. 3-4, pp. 207-218, 2003.
54. K. Safwen, S. Selima, E. Mohamed et al., "Protective effect of grape seed and skin extract on cerebral ischemia in rat: implication of transitionmetals," International Journal of Stroke, 2014.
55. H.-Z. Chen, S. Guo, Z.-Z. Li et al., "A critical role for interferon regulatory factor 9 in cerebral ischemic stroke," Journal of Neuroscience, vol. 34, no. 36, pp. 11897-11912, 2014.
56. A. A. Abd-Elsameea, A. A. Moustaf, and A. M. Mohamed, "Modulation of the oxidative stress by metformin in the cerebrum of rats exposed to global cerebral ischemia and ischemia/reperfusion," European Review for Medical and Pharmacological Sciences, vol. 18, no. 16, pp. 2387-2392, 2014.
57. J.-C. Lee and M.-H. Won, "Neuroprotection of antioxidant enzymes against transient global cerebral ischemia in gerbils," Anatomy & Cell Biology, vol. 47, no. 3, pp. 149-156, 2014.
58. L. Domański, B. Dołegowska, K. Safranow et al., "Early phase of reperfusion of human kidney allograft does not affect an erythrocyte anti-oxidative system," Nephrology, vol. 11, no. 5, pp. 467-470, 2006.
59. B. R. S. Broughton, D. C. Reutens, and C. G. Sobey, "Apoptotic mechanisms after cerebral ischemia," Stroke, vol. 40, no. 5, pp. e331-e339, 2009.
60. I. Dalle-Donne, R. Rossi, D. Giustarini, A. Milzani, and R. Colombo, "Protein carbonyl groups as biomarkers of oxidative stress," Clinica Chimica Acta, vol. 329, no. 1-2, pp. 23-38, 2003.
61. I. Dalle-Donne, D. Giustarini, R. Colombo, R. Rossi, and A. Milzani, "Protein carbonylation in human diseases," Trends in Molecular Medicine, vol. 9, no. 4, pp. 169-176, 2003.
62. Z. Wang, T. Liu, L. Gan et al., "Shikonin protects mouse brain against cerebral ischemia/reperfusion injury through its antioxidant activity," European Journal of Pharmacology, vol. 643, no. 2-3, pp. 211-217, 2010.
63. B. Groitl and U. Jakob, "Thiol-based redox switches," Biochimica et Biophysica Acta - Proteins and Proteomics, vol. 1844, no. 8, pp. 1335-1343, 2014.
64. N.-W. Tsai, Y.-T. Chang, C.-R. Huang et al., "Association between oxidative stress and outcome in different subtypes of acute ischemic stroke," BioMed Research International, vol. 2014, Article ID 256879, 7 pages, 2014.
65. F. Wang, W. Liang, C. Lei et al., "Combination of HBO and memantine in focal cerebral ischemia: is there a synergistic effect?" Molecular Neurobiology, 2014.
66. M. Bijak, M. Ponczek, J. Saluk, M. Chabielska, J. Stepniak, and P. Nowak, "Peroxynitrite a strong biological oxidant," Chemical News, vol. 66, 2012.
67. N.W. Kooy, J. A. Royall, Y. Z. Ye, D. R. Kelly, and J. S. Beckman, "Evidence for in vivo peroxynitrite production in human acute lung injury," American Journal of Respiratory and Critical Care Medicine, vol. 151, no. 4, pp. 1250-1254, 1995.
68. N. Fukuyama, Y. Takebayashi, M. Hida, H. Ishida, K. Ichimori, and H. Nakazawa, "Clinical evidence of peroxynitrite formation in chronic renal failure patients with septic shock," Free Radical Biology and Medicine, vol. 22, no. 5, pp. 771-774, 1997.
69. Y. Hayashi, Y. Sawa, M. Nishimura et al., "Peroxynitrite, a product between nitric oxide and superoxide anion, plays a cytotoxic role in the development of post-bypass systemic inflammatory response," European Journal of Cardio-Thoracic Surgery, vol. 26, no. 2, pp. 276-280, 2004.
70. D. Salvemini and S. Cuzzocrea, "Oxidative stress in septic shock and disseminated intravascular coagulation," Free Radical Biology and Medicine, vol. 33, no. 9, pp. 1173-1185, 2002.
71. C. Szabó, "Multiple pathways of peroxynitrite cytotoxicity," Toxicology Letters, vol. 140-141, pp. 105-112, 2003.
72. M. Hoffman, "Alterations of fibrinogen structure in human disease," Cardiovascular and Hematological Agents in Medicinal Chemistry, vol. 6, no. 3, pp. 206-211, 2008.
73. C. Vadseth, J. M. Souza, L. Thomson et al., "Pro-thrombotic state induced by post-translational modification of fibrinogen by reactive nitrogen species," The Journal of Biological Chemistry, vol. 279, no. 10, pp. 8820-8826, 2004.
74. D. F. Bas, M. A. Topcuoglu, Y. Gursoy-Ozdemir, I. Saatci, E. Bodur, and T. Dalkara, "Plasma 3-nitrotyrosine estimates the reperfusion-induced cerebrovascular stress, whereas matrix metalloproteinases mainly reflect plasma activity: a study in patients treated with thrombolysis or endovascular recanalization," Journal ofNeurochemistry, vol. 123, no. 2, pp. 138-147, 2012.
75. M. Coucha, W. Li, M. H. Johnson, S. C. Fagan, and A. Ergul, "Protein nitration impairs the myogenic tone of rat middle cerebral arteries in both ischemic and nonischemic hemispheres after ischemic stroke," The American Journal of Physiology - Heart and Circulatory Physiology, vol. 305, no. 12, pp. H1726-H1735, 2013.
76. M. Tajes, G. Ill-Raga, E. Palomer et al., "Nitro-oxidative stress after neuronal ischemia induces protein nitrotyrosination and cell death," OxidativeMedicine and Cellular Longevity, vol. 2013, Article ID 826143, 9 pages, 2013.
77. D. Venarucci, V. Venarucci, A. Vallese et al., "Free radicals: important cause of pathologies refer to ageing," Panminerva Medica, vol. 41, pp. 335-339, 1999.
78. E. Miller, M. Mrowicka, K. Malinowska, J. Mrowicki, J. Saluk- Juszczak, and J. Kedziora, "Effects of whole-body cryotherapy on a total antioxidative status and activities of antioxidative enzymes in blood of depressive multiple sclerosis patients," World Journal of Biological Psychiatry, vol. 12, no. 3, pp. 223-227, 2011.